Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway
<p>Abstract</p> <p>Backgroud</p> <p>Cerebral vasospasm (CVS) and early brain injury remain major causes of morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH). Hydroxymethylglutaryl coenzyme A reductase inhibitors, also known as statins, has the neuro...
Main Authors: | Shi-guang Zhao, Zhi-dan Sun, Wei Liu, Cheng Gao, Xiang-zhen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | BMC Neuroscience |
Online Access: | http://www.biomedcentral.com/1471-2202/10/7 |
Similar Items
-
Cerebral vasospasm following traumatic subarachnoid hemorrhage
by: Bahram Aminmansour, et al.
Published: (2009-11-01) -
Mitigation effect of atorvastatin on cerebral vasospasm after subarachnoid hemorrhage in rats and its effect on expression of Mitofusin-2 and BDNF
by: Peng-Fei Hou, et al.
Published: (2019-07-01) -
Management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
by: Mohamed Shehabeldin, et al.
Published: (2017-07-01) -
Cerebral vasospasm after subarachnoid hemorrhage: Developing treatments
by: Alvin Y. Chan, et al.
Published: (2021-03-01) -
Anti-inflammatory study of 6-mercaptopurine and Atorvastatin in vasospasm after experimental subarachnoid hemorrhage
by: Chih-Zen Chang, et al.
Published: (2010)